Sunday, November 22, 2026

Trump administration gears up for new tariffs on select drugmakers

Date:

The Trump administration is set to announce tariffs as soon as Thursday on drugmakers that haven’t struck deals guaranteeing low prices in the US, according to people familiar with the plan, the latest move to tax imported goods on national security grounds.President Donald Trump has been threatening tariffs on the pharmaceutical industry for the past year, which could range from 100% to 200% in an effort to force pharmaceutical companies to return manufacturing to the US and to cut drug prices for American patients.

Most of the major drug companies, including Pfizer Inc. and Eli Lilly & Co., have struck deals with the White House in exchange for a three-year reprieve from any such levies.
The new tariffs stem from an investigation under Section 232 of the Trade Expansion Act. Companies that don’t have agreements and aren’t in negotiations with the administration will be subject to 100% tariffs, said the people, who requested anonymity to discuss matters that aren’t public.Also Read: HDFC Bank is cancelling increments, ESOPs for 12 accused in AT-1 scandal: SourcesThe plans aren’t yet final and could still change, the people said. There could also be exemptions for certain medicines and disease categories, they said.

The White House didn’t immediately respond to a request for comment.

Trump has been talking about the US drug supply since he began rolling out his tariff agenda, wringing concessions from pharmaceutical companies on domestic manufacturing and the cost of medicine in exchange for promises of tariff relief.

The industry was spared from the global levies he imposed in 2025, which were struck down by the Supreme Court in February, after the administration negotiated one-off deals with more than a dozen individual companies.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

CLSA sees better US-India trade outlook; expects Fed and RBI to raise rates in December

The US is likely to push ahead with trade...

‘Trump has cost us’: After midterm losses, MAGA asks if it’s over

As Republicans faced a nationwide drubbing in Tuesday’s midterm...

Prashant Jain sees 12-15% annual returns from Indian equities over 3-5 years

Question We've had a very painful period for the equity...

Raamdeo Agrawal sees FIIs return as earnings improve and valuations turn attractive

Question Looking at the valuation compression across the market, are...